Kamal Hamed, Chief Medical Officer at Spero Therapeutics, Inc. (SPRO), sold 78,992 shares at $1.27 ($100K) on 2023-09-13, disclosed to the SEC on 2023-09-15.
Open-market sale of $100k SPRO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.27 | 39,496 | $50K | 50.0% |
| 2 | $1.27 | 39,496 | $50K | 50.0% |
| Total | $1.27 avg | 78,992 | $100K | 100% |